Single chain recombinant t cell receptors
CA 2501870 C · Owner: Glick, Meir · Inventors: Jakobsen, Bent Karsten; Glick, Meir
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A single chain T cell receptor (scTCR) comprising an a segment constituted by a TCR .alpha. chain variable region sequence fused to the N terminus of a TCR .alpha. chain constant region extracellular sequence a .beta. segment , constituted by a TCR .beta. chain variable region fused to the N terminus of a TCR .beta. chain constant region extracellular sequence and a linker sequence , linking the C terminus of the .alpha. segment to the N terminus of the .beta. segment, or vice versa, the constant region extracellular sequences of the .alpha.and .beta. segments being linked by a disulfide bond the length of the , linker sequence and the position of the disulfide bond being such that the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2003 and granted July 2, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.